Intra-Cellular Therapies Inc (ITCI)
85.45
-0.19
(-0.22%)
USD |
NASDAQ |
Nov 21, 16:00
87.72
+2.27
(+2.66%)
Pre-Market: 08:16
Intra-Cellular Therapies Total Liabilities (Quarterly): 179.62M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 179.62M |
| June 30, 2024 | 175.89M |
| March 31, 2024 | 147.54M |
| December 31, 2023 | 136.87M |
| September 30, 2023 | 116.98M |
| June 30, 2023 | 106.51M |
| March 31, 2023 | 94.55M |
| December 31, 2022 | 98.71M |
| September 30, 2022 | 96.58M |
| June 30, 2022 | 89.71M |
| March 31, 2022 | 75.83M |
| December 31, 2021 | 72.03M |
| September 30, 2021 | 70.22M |
| June 30, 2021 | 72.11M |
| March 31, 2021 | 62.34M |
| December 31, 2020 | 60.45M |
| September 30, 2020 | 61.90M |
| June 30, 2020 | 61.40M |
| March 31, 2020 | 50.79M |
| December 31, 2019 | 56.18M |
| September 30, 2019 | 53.64M |
| June 30, 2019 | 53.09M |
| March 31, 2019 | 54.36M |
| Date | Value |
|---|---|
| December 31, 2018 | 39.49M |
| September 30, 2018 | 31.96M |
| June 30, 2018 | 21.69M |
| March 31, 2018 | 22.45M |
| December 31, 2017 | 17.05M |
| September 30, 2017 | 14.75M |
| June 30, 2017 | 9.874M |
| March 31, 2017 | 19.27M |
| December 31, 2016 | 13.40M |
| September 30, 2016 | 143.25M |
| June 30, 2016 | 21.64M |
| March 31, 2016 | 10.92M |
| December 31, 2015 | 7.861M |
| September 30, 2015 | 11.27M |
| June 30, 2015 | 9.839M |
| March 31, 2015 | 14.75M |
| December 31, 2014 | 10.56M |
| September 30, 2014 | 3.578M |
| June 30, 2014 | 2.739M |
| March 31, 2014 | 3.912M |
| December 31, 2013 | 6.834M |
| September 30, 2013 | 7.775M |
| June 30, 2013 | 0.033M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
50.79M
Minimum
Mar 2020
179.62M
Maximum
Sep 2024
94.31M
Average
82.77M
Median
Total Liabilities (Quarterly) Benchmarks
| Ionis Pharmaceuticals Inc | 2.419B |
| AbbVie Inc | 137.35B |
| NovaBay Pharmaceuticals Inc | 2.805M |
| Palatin Technologies Inc | 11.10M |
| iBio Inc | 6.763M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.324B |
| Shareholders Equity (Quarterly) | 1.145B |
| Current Ratio | 7.656 |